SAL0119

To evaluate the safety and tolerability of a single oral administration of SAL0119 tablets in healthy subjects; to evaluate the pharmacokinetic characteristics of a single oral administration of SAL0119 tablets in healthy subjects; to explore the effect of food on the pharmacokinetic characteristics of SAL0119 tablets in healthy subjects; if necessary, to preliminarily identify metabolites in blood, urine, and feces, and to evaluate the metabolic transformation of SAL0119 tablets in healthy subjects.